Dr Reddys Laboratories Ltd Company Summary

Dr. Reddy’s Laboratory has launched with the vision to make easier access to affordable and superior quality medicine across hospitals, clinics and medical shops. The entity has become a full-fledged pharmaceutical production company through its early venture into Active Pharmaceutical Ingredients (APIs). APIs are the components of medicines that produce the intended therapeutic effect for the treatment and prevention of disease.

Company Overview

Dr. Reddy has established its presence in the field of generics, branded formulations, biosimilars, APIs, and proprietary products. All of this research is connected with the organisation’s root, at its headquarters, situated in Hyderabad, Telangana, India.

Founding & Evolution

• Founded: Dr. Reddy’s Laboratories Ltd was founded in 1984 as an API manufacturer.
• Year of Listing: The company was listed in the BSE and NSE in 1986, and on the New York Stock Exchange (NYSE) through ADRs.
• Leadership: Dr. Reddy’s Laboratories Ltd is led by Co-Chairman & MD: G.V. Prasad and Chief Executive Officer: Erez Israeli.
• Strategic Acquisitions & Alliances: The company has embarked on acquisitions, biosimilar development, API collaborations and complex generics as a way to strengthen global competitiveness.

Scale and Presence

The laboratory works in the regulated and semi-regulated markets throughout the pharmaceutical value chain.

• Business Footprint: Dr. Reddy’s Laboratories sells its products in India, the US, Europe, Russia & CIS countries, Latin America, and Asia-Pacific.
• Manufacturing Network: Dr. Reddy’s Laboratories are FDA-approved, and their manufacturing plants are located in Andhra Pradesh and Telangana.
• Employees: The company has about 26,000 employees, including in R&D, manufacturing, quality, supply chain, sales and corporate functions.
• Customer Base: Retail consumers, hospitals, distributors, global pharmaceutical companies and institutional partners.

Business Segments

The diversified business of Dr. Reddy’s Laboratories includes the following verticals in the pharmaceutical ecosystem:

• Global Generics: Dr. Reddy’s Laboratories has a portfolio of chronic and acute treatments, including oncology, cardiovascular, dermatology, gastrointestinal and anti-infective segments.
• Pharmaceutical Services & Active Ingredients (PSAI): The Laboratory provides active ingredients and custom pharmaceutical services to multinational drug manufacturers.
• Proprietary Products: Specialises in niche formulations, digital health products and specialty products.

Leadership Team

Top Mutual Funds Invested in Dr. Reddy’s Laboratories (As on 31st October 2025)